Company news

MeiraGTx Holdings plc news in 2021

MeiraGTx Holdings plc's news releases, calls and decks from 2021, newest first.

View company

MeiraGTx to Host a Virtual Research and Development Day on Gene Regulation

December 13, 2021

MeiraGTx Announces Positive Preliminary Data from the AQUAx Phase 1 Clinical Trial of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia

December 6, 2021

MeiraGTx to Provide a Xerostomia Clinical Program Update and Host a Virtual Research and Development Day on Gene Regulation

November 28, 2021

MeiraGTx Reports Third Quarter 2021 Financial and Operational Results

November 9, 2021

MeiraGTx to Participate in Upcoming Virtual Investor Conferences

November 8, 2021

MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress

October 18, 2021

MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference

September 27, 2021

MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa

September 8, 2021

MeiraGTx Reports Second Quarter 2021 Financial and Operational Results

August 10, 2021

MeiraGTx Reports First Quarter 2021 Financial and Operational Results

May 10, 2021

MeiraGTx Announces Participation at Upcoming Investor Conferences

May 4, 2021

MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit

April 18, 2021

MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results

March 10, 2021

MeiraGTx to Present at the 2021 Barclays Global Healthcare Conference

March 3, 2021

MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia

January 25, 2021

Decks in 2021